COMMUNIQUÉS West-GlobeNewswire

Guerbet : Q1 2024 revenue.

25/04/2024 - 17:45

Q1 2024 revenue Quarterly activity Revenue: €194.3m, up 8.8% at CER 1 Growth remains particularly strong in Asia (+26.8% at CER) and the Americas (+20.1% at CER); the EMEA region (-6.2% at CER) was temporarily impacted [...]

Ibogaine Treatment for Borderline Personality Disorder Launched by Ibogaine By David Dardashti

25/04/2024 - 16:54

New Protocol Developed to Provide Holistic, Compassionate Treatment MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the launch of a unique therapy protocol designed to provide [...]

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

25/04/2024 - 16:44

HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market (“Nasdaq”) on April [...]

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab

25/04/2024 - 16:00

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug [...]

RS BioTherapeutics Adds Jane Wright-Mitchell, Pharm.D., J.D. to Business Advisory Board

25/04/2024 - 16:00

Ms. Wright-Mitchell to serve as fractional General Counsel and Compliance Advisor CUMBERLAND, Md., April 25, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

25/04/2024 - 15:30

ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 25 APRIL 2024 at 16.30 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

25/04/2024 - 15:29

Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82% 690 subjects analyzed including previously [...]

Using AI to Improve Diagnosis of Rare Genetic Disorders

25/04/2024 - 15:19

HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to make the process [...]

GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

25/04/2024 - 15:15

Live webcast on Wednesday, May 1 st at 3:00 PM ET LA JOLLA, CA, April 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of [...]

Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

25/04/2024 - 15:14

LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a single-payer national health insurance system LIFEHAB is targeting [...]

Precision Optics Announces Receipt of $1.26 Million Follow On Production Order from Large Defense Company

25/04/2024 - 15:00

GARDNER, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today [...]

BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort

25/04/2024 - 15:00

Call Scheduled for Study Clinical Leadership to Discuss Results and Details on Pivotal Randomized Trial SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and [...]

INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

25/04/2024 - 15:00

Boca Raton, Florida, April 25, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune [...]

Opthea to Present at the OIS Retina Innovation Summit at ARVO

25/04/2024 - 15:00

MELBOURNE, Australia and PRINCETON, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat [...]

Medigene presents streamlined 6-day, high stemness TCR-T therapy production process

25/04/2024 - 15:00

Planegg/Martinsried, April 25, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid [...]

Cannabix’s Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA

25/04/2024 - 14:45

Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement, employers and other organizations tools to enhance public safety VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE [...]

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

25/04/2024 - 14:45

OCALA, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO [...]

International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18

25/04/2024 - 14:45

With Over $675,000 Raised, the Gala Benefits the Peter Boyle Research Fund and Celebrates Groundbreaking Myeloma Research, Education, Support, and Advocacy STUDIO CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- On [...]

NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility

25/04/2024 - 14:35

TORONTO and HAIFA, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company is pleased to announce that its [...]